Singular Genomics Systems Inc (OMIC)
0.401
0.00 (0.00%)
USD |
NASDAQ |
Apr 30, 16:00
0.412
+0.01
(+2.74%)
Pre-Market: 20:00
Singular Genomics Systems Cash from Investing (TTM): 13.81M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.81M |
| September 30, 2023 | 13.33M |
| June 30, 2023 | -0.087M |
| March 31, 2023 | 24.99M |
| December 31, 2022 | -39.57M |
| September 30, 2022 | -63.06M |
| June 30, 2022 | -30.65M |
| Date | Value |
|---|---|
| March 31, 2022 | -32.01M |
| December 31, 2021 | -130.86M |
| September 30, 2021 | -99.88M |
| June 30, 2021 | -87.62M |
| March 31, 2021 | -68.85M |
| December 31, 2020 | 24.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-130.86M
Minimum
Dec 2021
24.99M
Maximum
Mar 2023
-36.65M
Average
-32.01M
Median
Mar 2022
Cash from Investing (TTM) Benchmarks
| Bruker Corp | -326.00M |
| Azenta Inc | 473.42M |
| Harvard Bioscience Inc | -1.799M |
| Bionano Genomics Inc | 24.16M |
| Akoya Biosciences Inc | 3.347M |